AIM
RCEL icon

Artemis Investment Management’s Avita Medical RCEL Stock Holding History

Artemis Investment Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-91,022
Closed -$771K – 286
2022
Q1 		$771K Buy
91,022
+22,031
+32% +$203K 0.01% 252
2021
Q4 		$826K Buy
68,991
+11,812
+21% +$180K 0.01% 261
2021
Q3 		$1.01M Buy
57,179
+15,201
+36% +$287K 0.01% 283
2021
Q2 		$862K Buy
+41,978
New +$827K 0.01% 276

Other funds holding RCEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Artemis Investment Management's RCEL Position: Q2 2022 in Review

Artemis Investment Management sold out of Avita Medical (RCEL) in Q2 2022, closing a stake of 91,022 shares — an estimated $771K sold.

Artemis Investment Management first reported a position in RCEL in Q2 2021 and held it in 4 quarters. The position peaked at $1.01M in Q3 2021. 56 funds tracked by Wall St. Rank hold RCEL as of Q2 2022.

  • Artemis Investment Management reported no remaining Avita Medical position as of Q2 2022 after selling out during the quarter.
  • Artemis Investment Management sold 91,022 Avita Medical shares in Q2 2022, an estimated $771K.
  • Artemis Investment Management first reported a position in Avita Medical in Q2 2021 and held it in 4 quarters.
  • Artemis Investment Management's Avita Medical position peaked at $1.01M in Q3 2021.
  • 56 funds tracked by Wall St. Rank held Avita Medical as of Q2 2022.

Based on Artemis Investment Management's 13F filing for Q2 2022, filed 22 Jul 2022.